CLOROX COMPANY (CLX) Fundamental Analysis & Valuation

NYSE:CLX • US1890541097

Current stock price

102.42 USD
+0.38 (+0.37%)
At close:
103.84 USD
+1.42 (+1.39%)
After Hours:

This CLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CLX Profitability Analysis

1.1 Basic Checks

  • In the past year CLX was profitable.
  • In the past year CLX had a positive cash flow from operations.
  • In the past 5 years CLX has always been profitable.
  • Each year in the past 5 years CLX had a positive operating cash flow.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of CLX (13.45%) is better than 91.67% of its industry peers.
  • The Return On Invested Capital of CLX (21.55%) is better than 83.33% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLX is above the industry average of 14.94%.
  • The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.45%
ROE N/A
ROIC 21.55%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

  • The Profit Margin of CLX (11.17%) is better than 66.67% of its industry peers.
  • CLX's Profit Margin has declined in the last couple of years.
  • CLX has a Operating Margin (15.21%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CLX has declined.
  • CLX has a better Gross Margin (44.16%) than 66.67% of its industry peers.
  • CLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.21%
PM (TTM) 11.17%
GM 44.16%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CLX Health Analysis

2.1 Basic Checks

  • CLX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CLX has less shares outstanding than it did 1 year ago.
  • CLX has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLX has a worse debt to assets ratio.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.01 indicates that CLX is not in any danger for bankruptcy at the moment.
  • CLX has a Altman-Z score of 3.01. This is comparable to the rest of the industry: CLX outperforms 50.00% of its industry peers.
  • The Debt to FCF ratio of CLX is 3.59, which is a good value as it means it would take CLX, 3.59 years of fcf income to pay off all of its debts.
  • CLX's Debt to FCF ratio of 3.59 is in line compared to the rest of the industry. CLX outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.59
Altman-Z 3.01
ROIC/WACC2.68
WACC8.03%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 0.74 indicates that CLX may have some problems paying its short term obligations.
  • CLX's Current ratio of 0.74 is on the low side compared to the rest of the industry. CLX is outperformed by 83.33% of its industry peers.
  • CLX has a Quick Ratio of 0.74. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLX has a worse Quick ratio (0.48) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.48
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CLX Growth Analysis

3.1 Past

  • The earnings per share for CLX have decreased by -5.48% in the last year.
  • CLX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.01% yearly.
  • Looking at the last year, CLX shows a decrease in Revenue. The Revenue has decreased by -5.68% in the last year.
  • Measured over the past years, CLX shows a small growth in Revenue. The Revenue has been growing by 1.11% on average per year.
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
Revenue 1Y (TTM)-5.68%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.95% on average over the next years.
  • Based on estimates for the next years, CLX will show a small growth in Revenue. The Revenue will grow by 1.34% on average per year.
EPS Next Y-22.64%
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%
EPS Next 5Y2.95%
Revenue Next Year-7.75%
Revenue Next 2Y-0.35%
Revenue Next 3Y0.95%
Revenue Next 5Y1.34%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLX Valuation Analysis

4.1 Price/Earnings Ratio

  • CLX is valuated correctly with a Price/Earnings ratio of 15.61.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLX is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 24.75. CLX is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 14.88, the valuation of CLX can be described as correct.
  • CLX's Price/Forward Earnings ratio is in line with the industry average.
  • CLX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.61
Fwd PE 14.88
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • CLX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • CLX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.92
EV/EBITDA 11.67
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • CLX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)15.41
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. CLX Dividend Analysis

5.1 Amount

  • CLX has a Yearly Dividend Yield of 4.85%, which is a nice return.
  • CLX's Dividend Yield is rather good when compared to the industry average which is at 2.82. CLX pays more dividend than 83.33% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.85%

5.2 History

  • The dividend of CLX has a limited annual growth rate of 2.88%.
  • CLX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • CLX pays out 79.74% of its income as dividend. This is not a sustainable payout ratio.
  • CLX's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP79.74%
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CLX Fundamentals: All Metrics, Ratios and Statistics

CLOROX COMPANY

NYSE:CLX (3/30/2026, 8:04:00 PM)

After market: 103.84 +1.42 (+1.39%)

102.42

+0.38 (+0.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)02-03
Earnings (Next)05-04
Inst Owners84.93%
Inst Owner Change-3.66%
Ins Owners0.41%
Ins Owner Change5.64%
Market Cap12.38B
Revenue(TTM)6.76B
Net Income(TTM)755.00M
Analysts55.56
Price Target126.88 (23.88%)
Short Float %6.29%
Short Ratio3.38
Dividend
Industry RankSector Rank
Dividend Yield 4.85%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP79.74%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-22
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.49%
Min EPS beat(2)-3.99%
Max EPS beat(2)6.97%
EPS beat(4)2
Avg EPS beat(4)5.85%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)6
Avg EPS beat(8)12.97%
EPS beat(12)10
Avg EPS beat(12)48.42%
EPS beat(16)13
Avg EPS beat(16)42.93%
Revenue beat(2)2
Avg Revenue beat(2)0.98%
Min Revenue beat(2)0.9%
Max Revenue beat(2)1.06%
Revenue beat(4)3
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)1.58%
Revenue beat(8)5
Avg Revenue beat(8)0.09%
Revenue beat(12)9
Avg Revenue beat(12)2.15%
Revenue beat(16)11
Avg Revenue beat(16)1.6%
PT rev (1m)0%
PT rev (3m)1.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.54%
EPS NY rev (1m)0.28%
EPS NY rev (3m)-0.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 15.61
Fwd PE 14.88
P/S 1.83
P/FCF 15.92
P/OCF 12.58
P/B N/A
P/tB N/A
EV/EBITDA 11.67
EPS(TTM)6.56
EY6.4%
EPS(NY)6.88
Fwd EY6.72%
FCF(TTM)6.43
FCFY6.28%
OCF(TTM)8.14
OCFY7.95%
SpS55.89
BVpS-1.03
TBVpS-15.81
PEG (NY)N/A
PEG (5Y)15.41
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 13.45%
ROE N/A
ROCE 31.48%
ROIC 21.55%
ROICexc 23.01%
ROICexgc 49.39%
OM 15.21%
PM (TTM) 11.17%
GM 44.16%
FCFM 11.51%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.59
Debt/EBITDA 2.23
Cap/Depr 92.38%
Cap/Sales 3.05%
Interest Coverage 250
Cash Conversion 78.66%
Profit Quality 103.05%
Current Ratio 0.74
Quick Ratio 0.48
Altman-Z 3.01
F-Score6
WACC8.03%
ROIC/WACC2.68
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
EPS Next Y-22.64%
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%
EPS Next 5Y2.95%
Revenue 1Y (TTM)-5.68%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%
Revenue Next Year-7.75%
Revenue Next 2Y-0.35%
Revenue Next 3Y0.95%
Revenue Next 5Y1.34%
EBIT growth 1Y-2.93%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year6.04%
EBIT Next 3Y8.42%
EBIT Next 5Y7.05%
FCF growth 1Y6.87%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y4.24%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 5 / 10 to CLX.


What is the valuation status for CLX stock?

ChartMill assigns a valuation rating of 4 / 10 to CLOROX COMPANY (CLX). This can be considered as Fairly Valued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CLOROX COMPANY (CLX) stock?

The Price/Earnings (PE) ratio for CLOROX COMPANY (CLX) is 15.61 and the Price/Book (PB) ratio is -99.07.


How sustainable is the dividend of CLOROX COMPANY (CLX) stock?

The dividend rating of CLOROX COMPANY (CLX) is 8 / 10 and the dividend payout ratio is 79.74%.